UK genetics and insurance committee established:
This article was originally published in Clinica
The UK Department of Health has set up a Genetics and Insurance Committee in response to concerns over the use of genetic tests by insurers. Its terms of reference are to develop criteria for the evaluation of genetic tests, their application to particular conditions and their reliability and relevance to insurance; to evaluate tests against those criteria; and to report to government ministers on proposals from insurance providers and the level of compliance by industry with the committee's recommendations. Work has already begun on a mechanism to assess the use of tests for rare genetic disorders, including Huntington's disease.
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.